rxstat › Classes › Agents For Treatment Of Hemorrhoids And Anal Fissures For Topical Use
Agents For Treatment Of Hemorrhoids And Anal Fissures For Topical Use: shortage status in Canada
3 of the 6 agents for treatment of hemorrhoids and anal fissures for topical use rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Hydrocortisone Zinc (Anusol-Hc) Partial shortage 1 of 5 reported products affected
Hydrocortisone Zinc Benzocaine (Rectogel Hc) Partial shortage 1 of 1 reported products affected
Pramoxine Hydrocortisone (Proctofoam Hc) Partial shortage 1 of 1 reported products affected · est. return Aug 10, 2026
Pramoxine Hydrocortisone Zinc (Proctodan-Hc) Shortage anticipated 0 of 2 reported products affected
Esculin Framycetin Dibucaine Hydrocortisone (Proctosedyl) No current shortage
Zinc Hydrocortisone (Jampzinc-Hc) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.